Management of Dextromethorphan-Induced Autonomic Instability
For dextromethorphan-induced tachycardia and hypertension, provide supportive care with benzodiazepines for agitation, consider short-acting beta-blockers for persistent tachycardia, and use short-acting antihypertensives only if blood pressure remains dangerously elevated despite supportive measures.
Immediate Management Approach
The primary strategy is supportive care because dextromethorphan toxicity is self-limited and resolves as the drug is metabolized 1. When abused at doses >2 mg/kg, dextromethorphan produces dissociative effects similar to ketamine and phencyclidine, with autonomic instability manifesting as tachycardia and hypertension 1.
Step 1: Supportive Measures First
- Control agitation immediately with benzodiazepines (lorazepam 1-2 mg IV or diazepam 5-10 mg IV), as agitation and the dissociative state drive much of the autonomic instability
- Place patient in quiet, low-stimulation environment
- Continuous cardiac monitoring and frequent vital sign assessment
- IV access and fluid resuscitation if needed
- Contact Poison Control Center (1-800-222-1222) 2
Step 2: Pharmacologic Intervention for Persistent Autonomic Instability
For tachycardia:
- If heart rate remains >120 bpm despite benzodiazepines, consider short-acting beta-blockers (esmolol 500 mcg/kg loading dose over 1 minute, then 50-200 mcg/kg/min infusion)
- Avoid long-acting agents as symptoms typically resolve within hours
For hypertension:
- Treat only if systolic BP >180 mmHg or diastolic >120 mmHg persists after sedation
- Use short-acting agents: labetalol 10-20 mg IV bolus or nicardipine infusion starting at 5 mg/hour
- Target systolic BP 140-160 mmHg initially, not aggressive normalization
Step 3: Monitor for Complications
Watch for co-ingested substances, as dextromethorphan products often contain antihistamines (anticholinergic toxicity) or sympathomimetic amines (worsened hypertension) 1.
Critical Caveats
Naloxone is controversial - conflicting reports exist regarding effectiveness for dextromethorphan toxicity 1. It may be attempted if respiratory depression is present, but do not expect reversal of autonomic instability.
Avoid aggressive blood pressure lowering - the labile nature of drug-induced autonomic instability means overly aggressive treatment can cause rebound hypotension as the drug effect wanes. The goal is preventing end-organ damage, not achieving normal blood pressure.
Do not use clonidine or other centrally-acting agents - while these treat hypertension in chronic autonomic dysfunction 3, they are inappropriate for acute dextromethorphan toxicity where the problem is transient sympathetic surge, not chronic autonomic failure.
The evidence base for dextromethorphan toxicity management is limited to case reports and clinical experience 1, making supportive care the cornerstone. Most patients recover fully within 6-12 hours with supportive measures alone.